Visioneering Technologies Inc
VTI
Company Profile
Business description
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sells, and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision, making it much easier for eye care professionals to fit their patients. It has two reportable segments; North America which includes its operations in the United States and Canada; and Europe/Asia Pacific which includes its operations outside North America.
Contact
30 Mansell Court
Suite 215
AlpharettaGA30076
USAT: +1 844 884-5367
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
ASX shares plunge but remain undervalued
Shares drop 17% after guidance is revised but we still see value.
stocks
Ask the analyst: Why have markets shunned APA Group?
Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,597.90 | 20.10 | 0.23% |
| CAC 40 | 7,490.28 | 37.86 | 0.51% |
| DAX 40 | 20,317.10 | 12.84 | -0.06% |
| Dow JONES (US) | 42,635.20 | 106.84 | 0.25% |
| FTSE 100 | 8,319.69 | 68.66 | 0.83% |
| HKSE | 19,240.89 | 38.95 | -0.20% |
| NASDAQ | 19,478.88 | 10.80 | -0.06% |
| Nikkei 225 | 39,605.09 | 375.97 | -0.94% |
| NZX 50 Index | 12,958.74 | 15.00 | 0.12% |
| S&P 500 | 5,918.25 | 9.22 | 0.16% |
| S&P/ASX 200 | 8,348.80 | 19.60 | 0.24% |
| SSE Composite Index | 3,211.39 | 18.77 | -0.58% |